Actively Recruiting
Blood Flow Restriction Training in Acute Geriatric Rehabilitation: Effects and Safety in Hospitalized Older Adults
Led by University Hospital, Bonn · Updated on 2026-05-14
60
Participants Needed
1
Research Sites
12 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are investigating the effects and safety of blood flow restriction training (BFR) on muscle strength and general health in older adults undergoing acute geriatric rehabilitation. The study focuses on patients aged 65 and older who have reduced muscle mass and strength due to age-related sarcopenia, which can increase the risk of falls and mobility problems. This randomized controlled trial aims to explore a potentially safer alternative to high-intensity resistance training, which can be challenging for older adults due to injury risk. Participants are randomly assigned to one of two groups. The intervention group receives blood flow restriction training using a stationary cycling ergometer five times a week for two weeks, with cycling intensity individualized and blood flow restricted at 60% limb occlusion pressure (LOP). The control group performs sham blood flow restriction training at 20 mmHg while cycling at an individualized intensity. Both training sessions are conducted in a hospital rehabilitation setting. During the study, researchers will assess muscle strength and mobility using the Timed Up and Go test before and after the two-week rehabilitation period. Participants will be monitored to evaluate the feasibility and safety of BFR training. The total duration of participation is two weeks, during which the effects of the training on muscle function and general health outcomes are closely observed.
CONDITIONS
Brief Title
Blood Flow Restriction Training in Acute Geriatric Rehabilitation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults over 65 years old
- Hospitalized for acute rehabilitation for about two weeks after a fracture near the hip joint
You will not qualify if you...
- Sickle Cell Anemia
- Blood vessel changes at the site of tourniquet application, such as stents
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 2 weeks
Participants receive blood flow restriction or sham blood flow restriction training on a stationary cycling ergometer.
5 visits per week
Trial Site Locations
Total: 1 location
1
St. Marien-Hospital Köln
Cologne, North Rhine-Westphalia, Germany, 50668
Actively Recruiting
Research Team
A
Alexander Franz, Dr. med., B.Sc.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here